| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 26,293 | -13,787 |
| Depreciation and amortization | 1,421 | 946 |
| Loss on disposal of property and equipment | -92 | -85 |
| Share-based compensation expense | 13,427 | 9,815 |
| Non-cash interest expense | 1,250 | 832 |
| Non-cash lease expense | 1,253 | 827 |
| Deferred income taxes | 42,547 | 14,775 |
| Accounts receivable, net | 38,475 | 4,282 |
| Prepaid expenses and other current assets | 719 | 471 |
| Other assets | -347 | -284 |
| Accounts payable and accrued expenses | 6,519 | -4,174 |
| Accrued research and development costs | -3,832 | -2,664 |
| Operating lease liabilities | -1,759 | -1,156 |
| Other liabilities | 4,105 | 3,856 |
| Net cash provided by operating activities | 52,469 | 4,886 |
| Purchases of property and equipment | 35 | 33 |
| Net cash used in investing activities | -35 | -33 |
| Proceeds from exercise of stock options and employee stock purchase plan | 94 | 94 |
| Net cash provided by (used in) financing activities | 94 | 94 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -680 | -654 |
| Net increase (decrease) in cash and cash equivalents | 51,848 | 4,293 |
| Cash and cash equivalents at beginning of period | 88,559 | - |
| Cash and cash equivalents at end of period | 140,407 | - |
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)